Sriram R on LinkedIn: Labcorp Announces First-of-Its-Kind Test for Early Indication of… (2024)

Labcorp Oncology's scientific team recently published a manuscript in Oncology and Therapy that discusses the negative impact of single-gene testing (SGT) done prior to comprehensive genomic profiling (CGP) for patients with non-small cell lung cancer. SGT before CGP doubled subsequent CGP test cancelations due to tissue insufficiency and increased DNA extraction failures. Read the full manuscript.#NSCLC #CGP #PrecisionOncology

3

Research published in the Chem journal highlighted a molecule developed by scientists that can help fight against Antimicrobial resistance (AMR) wherein a bacteria, virus, or fungi can become immune to medication.These molecules are low in toxicity to healthy human cells and could efficiently demolish the harmful bacteria.Know more.

3

Annual physical examinations are crucial for sustaining good health, yet a lot of Americans visit their physician only when an issue emerges. By offering employees the chance to be screened for underlying or chronic diseases and, if needed, begin treatment, health screenings can prevent reactive health care. Read more:

2

Researchers have identified human gut bacteria that produce an enzyme that can change artery-clogging cholesterol into a less harmful version that the body is unable to absorb. The results suggest potential therapies for hypercholesterolemia. Read more:

3

Labcorp® Plasma Focus™ is a sensitive and specific multi-solid tumor NGS test focused on biomarkers for FDA-approved therapies. It enables personalized care based on each patient's unique tumor to help improve outcomes. Learn more.

2

We recognize the link between human and environmental health and the leading role our company plays in creating a healthier world. We are proud to share our progress on initiatives that positively impact our employees, operations and the communities we serve.View our latest Corporate Responsibility Report.

1

Labcorp® Plasma Focus™ is a sensitive and specific multi-solid tumor NGS test focused on biomarkers for FDA-approved therapies. It enables personalized care based on each patient's unique tumor to help improve outcomes. Learn more.

4

Labcorp is proud to support United Rheumatology/Specialty Networks during their Spring National Conference in San Antonio, Texas, on Friday, April 19, where we will be connecting during their Rheumatology Roundtable and sharing our commitment to improve lives every day.Learn more about our broad capabilities in #AutoimmuneTesting in #Rheumatology.

1

Stress can significantly impact our physical and mental health. Learn the three biggest sources of stress and discover how you can help reduce stress for your employees.

1